CNY 18.55
(0.92%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 15.83 Billion | 15.74 Billion | 13.54 Billion | 10.3 Billion | 9.26 Billion | 9.13 Billion |
Cost of Revenue | 10.39 Billion | 9.98 Billion | 8.92 Billion | 6.7 Billion | 5.71 Billion | 6.15 Billion |
Gross Profit | 5.43 Billion | 5.75 Billion | 4.62 Billion | 3.6 Billion | 3.54 Billion | 2.97 Billion |
Operating Expenses | 5.31 Billion | 4.98 Billion | 3.87 Billion | 2.93 Billion | 2.7 Billion | 2.21 Billion |
Selling, General and Administrative Expenses | 2.86 Billion | 2.31 Billion | 1.2 Billion | 914.75 Million | 623.8 Million | 535.54 Million |
Research and Development Expenses | 2.55 Billion | 2.47 Billion | 1.75 Billion | 1.34 Billion | 1.2 Billion | 1.04 Billion |
Other Expenses | 176.04 Million | 200.12 Million | 914.98 Million | 673.99 Million | 870.74 Million | 1.62 Million |
Cost and Expenses | 15.45 Billion | 14.97 Billion | 12.8 Billion | 9.63 Billion | 8.42 Billion | 8.37 Billion |
Operating Income | 449.38 Million | 759.22 Million | 648.6 Million | 554.95 Million | 830.19 Million | 861.38 Million |
Interest Expense | 38.59 Million | 50.81 Million | 40.79 Million | 20.71 Million | 2.28 Million | 990.65 Thousand |
Income Tax Expense | -256 Million | -125.84 Million | -130.59 Million | -45.23 Million | 8.07 Million | 39.96 Million |
Earnings before Tax | 459.15 Million | 763.45 Million | 654.34 Million | 548.2 Million | 852.13 Million | 863 Million |
Net Income | 424.85 Million | 889.29 Million | 784.94 Million | 593.43 Million | 844.06 Million | 578.39 Million |
Earnings Per Share Basic | 0.73 | 1.52 | 1.35 | 1.02 | 1.45 | 0.99 |
Earnings Per Share Diluted | 0.73 | 1.52 | 1.35 | 1.02 | 1.45 | 0.99 |
Weighted Average Shares Outstanding | 583.48 Million | 583.28 Million | 583.28 Million | 583.28 Million | 583.28 Million | 583.28 Million |
Weighted Average Shares Outstanding (Diluted) | 583.48 Million | 583.28 Million | 583.28 Million | 583.28 Million | 583.28 Million | 583.29 Million |
Gross Margin | 0.34 | 0.37 | 0.34 | 0.35 | 0.38 | 0.33 |
EBIT Margin | 0.05 | 0.08 | 0.07 | 0.08 | 0.12 | 0.12 |
Profit Margin | 0.03 | 0.06 | 0.06 | 0.06 | 0.09 | 0.06 |
EBITDA | 815.13 Million | 1.07 Billion | 898.87 Million | 698.68 Million | 943.71 Million | 993.31 Million |
Earnings Before Tax Margin | 0.03 | 0.05 | 0.05 | 0.05 | 0.09 | 0.09 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 4.58 Billion | 4.14 Billion | 3.13 Billion | 15.83 Billion | 4.83 Billion | 4.08 Billion |
Cost of Revenue | 3.12 Billion | 2.91 Billion | 2.04 Billion | 10.39 Billion | 3.09 Billion | 2.59 Billion |
Gross Profit | 1.46 Billion | 1.22 Billion | 1.09 Billion | 5.43 Billion | 1.74 Billion | 1.48 Billion |
Operating Expenses | 1.15 Billion | 1.15 Billion | 1.12 Billion | 5.24 Billion | 1.82 Billion | 1.34 Billion |
Selling, General and Administrative Expenses | 1.75 Billion | 652.22 Million | 676.78 Million | - | 997.99 Million | 984.02 Million |
Research and Development Expenses | 499.83 Million | 479.17 Million | 529.2 Million | - | 801.39 Million | 676.19 Million |
Other Expenses | -1.09 Billion | -25.07 Million | -616.59 Thousand | 176.04 Million | -23.46 Million | -1.56 Million |
Cost and Expenses | 4.28 Billion | 4.07 Billion | 3.16 Billion | 15.64 Billion | 4.91 Billion | 3.94 Billion |
Operating Income | 270.44 Million | 67.45 Million | -34.56 Million | 188.72 Million | -82.34 Million | 127.56 Million |
Interest Expense | 14.1 Million | 15.05 Million | 8.17 Million | 34.93 Million | 6.75 Million | 5.74 Million |
Income Tax Expense | -13.56 Million | -34.07 Million | -59.45 Million | -256 Million | -92.4 Million | -61.42 Million |
Earnings before Tax | 278.69 Million | 174.31 Million | -35.17 Million | 424.73 Million | 99.88 Million | 127.53 Million |
Net Income | 137.61 Million | 113.61 Million | 11.55 Million | 424.85 Million | 122.04 Million | 104.52 Million |
Earnings Per Share Basic | 0.24 | 0.19 | 0.02 | - | 0.21 | 0.18 |
Earnings Per Share Diluted | 0.24 | 0.19 | 0.02 | - | 0.21 | 0.18 |
Weighted Average Shares Outstanding | 580.42 Million | 586.84 Million | 580.49 Million | 583.48 Million | 583.48 Million | 583.28 Million |
Weighted Average Shares Outstanding (Diluted) | 580.42 Million | 586.84 Million | 580.49 Million | 583.48 Million | 583.48 Million | 583.28 Million |
Gross Margin | 0.32 | 0.30 | 0.35 | 0.34 | 0.36 | 0.36 |
EBIT Margin | 0.06 | 0.04 | -0.00 | - | 0.00 | 0.04 |
Profit Margin | 0.03 | 0.03 | 0.00 | 0.03 | 0.03 | 0.03 |
EBITDA | 292.8 Million | 153.26 Million | -9.56 Million | - | 8.9 Million | 144.77 Million |
Earnings Before Tax Margin | 0.06 | 0.02 | -0.01 | 0.01 | -0.02 | 0.03 |
LRKKF
BPLPHARMA
3091
NTCIND
600983
8967